Ann: Response to Aware Query, page-79

Let me correct you the company will likely be a pure medtech player in future if they spin off vaccine division.

Let me respectively say that you talk alot of BS, sorry - you were convinced to me that SP was going to hit $1+ by end of June - where I am standing now that is liking getting nigh impossible, I find it hard to understand you anymore even if there are gems hidden maybe in your text. then you got me thinkging - Suckii are you paid as freelancer to post lots of drivel on about wonders of Admedus on HC??? I don't need to see how wonderful everything is going to be every day, world class, best, etc, etc numbers tell the story and ROI and that is pretty sorry story on this day.

however I agree Prof Frazer and Prof Neethling are worldclass and company is very very lucky that they are with them. whoever got these guys onboard was a shrewd move- i am sure they dismayed by the shannigans of management.